Glycans hold immense potential as biomarkers for various diseases, offering unique signatures that reflect alterations in cellular function and health status.
Moreover, glycan structures present attractive targets for therapeutic intervention, with emerging strategies aiming to modulate glycan-mediated processes for therapeutic benefit.
Translating Glycomics Discoveries into...
In the ever-evolving landscape of biotechnology, the Global Cell Penetrating Peptide (CPP) industry stands at the forefront of innovation and opportunity. This segment, characterized by its ability to facilitate the intracellular delivery of therapeutic agents and biomolecules, is witnessing a surge in interest and investment. Let's delve deeper into the trends and forecasts shaping the future...